Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Mucopolysaccharidosis IV A: Molecular cloning of the human N-Acetylgalactosamine-6-sulfatase gene (GALNS) and analysis of the 5[prime]-flanking region

Journal Article · · Genomics; (United States)

Mucopolysaccharidosis IV A (MPS IV A) is the result of a genetic deficiency in a lysosomal hydrolase, N-acetylgalactosamine-6-sulfatase (GALNS). To investigate MPS IV A patients at the level of the genome, the authors analyzed the structure of the human GALNS-encoding gene. From the genomic library of a normal subject in [lambda]EMBL3, they isolated five overlapping clones covering the coding region of the GALNS cDNA and determined the structural organization. The gene is about 50 kb long and contains 14 exons. The 5[prime]-flanking region lacks a canonical TATA box and CCAAT sequences, but is G+C-rich (70.5%), with four GC boxes, characteristic of a housekeeping gene promoter. The transcription initiation site was determined by primer extension analysis, using RNA from human liver and Hela cells. Transcription was found to initiate at a few sites, the major ones being 58 and 22 bp upstream of the translation initiation codon. The 5[prime]-flanking region had promoter activity by transient expression, determined using a CAT assay. In addition, this region retained promoter activity, even in reverse orientation. The region -98 to -1 upstream of the ATG codon was defined by deletion analysis to be a minimal promoter. One GC box in this region is likely to be a binding site of a regulatory element. 36 refs., 4 figs., 1 tab.

OSTI ID:
6789611
Journal Information:
Genomics; (United States), Journal Name: Genomics; (United States) Vol. 20:1; ISSN GNMCEP; ISSN 0888-7543
Country of Publication:
United States
Language:
English